[Pharmacological characteristics and clinical efficacy of bosentan]

Nihon Yakurigaku Zasshi. 2005 Dec;126(6):407-18. doi: 10.1254/fpj.126.407.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / pharmacology*
  • Antihypertensive Agents / therapeutic use*
  • Bosentan
  • Disease Models, Animal
  • Drug-Related Side Effects and Adverse Reactions
  • Endothelin A Receptor Antagonists
  • Endothelin B Receptor Antagonists
  • Endothelin-1 / antagonists & inhibitors
  • Endothelin-1 / physiology
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / prevention & control
  • In Vitro Techniques
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Randomized Controlled Trials as Topic
  • Sulfonamides / adverse effects
  • Sulfonamides / pharmacology*
  • Sulfonamides / therapeutic use*
  • Vasoconstriction / drug effects

Substances

  • Antihypertensive Agents
  • Endothelin A Receptor Antagonists
  • Endothelin B Receptor Antagonists
  • Endothelin-1
  • Sulfonamides
  • Nitric Oxide Synthase
  • Bosentan